NO970081L - Method of folding proteins such as recombinant hirudin or epidermal growth factor - Google Patents
Method of folding proteins such as recombinant hirudin or epidermal growth factorInfo
- Publication number
- NO970081L NO970081L NO970081A NO970081A NO970081L NO 970081 L NO970081 L NO 970081L NO 970081 A NO970081 A NO 970081A NO 970081 A NO970081 A NO 970081A NO 970081 L NO970081 L NO 970081L
- Authority
- NO
- Norway
- Prior art keywords
- growth factor
- epidermal growth
- recombinant hirudin
- folding proteins
- correctly folded
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det er beskrevet en fremgangsmåte for fremstilling av et biologisk aktivt og korrekt foldet protein i nærvær av denatureringsmidler som urea eller guanidinhydro-klorid og separasjon av det korrekt foldede proteinet direkte derfra. Fremgangsmåten kan f.eks. anvendes ved renaturering av rekombinante proteiner som hirudln eller epidermisk vekstfaktor.A method is described for producing a biologically active and correctly folded protein in the presence of denaturants such as urea or guanidine hydrochloride and separating the correctly folded protein directly therefrom. The procedure can e.g. used in the renaturation of recombinant proteins such as hirudln or epidermal growth factor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94810437 | 1994-07-25 | ||
| PCT/EP1995/002720 WO1996003425A1 (en) | 1994-07-25 | 1995-07-12 | Process for folding of proteins like recombinant hirudin or epidermal growth factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO970081L true NO970081L (en) | 1997-01-09 |
| NO970081D0 NO970081D0 (en) | 1997-01-09 |
Family
ID=8218291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO970081A NO970081D0 (en) | 1994-07-25 | 1997-01-09 | Method of folding proteins such as recombinant hirudin or epidermal growth factor |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0804461A1 (en) |
| JP (1) | JPH11505507A (en) |
| AU (1) | AU3109795A (en) |
| CA (1) | CA2194177A1 (en) |
| FI (1) | FI970230A0 (en) |
| IL (1) | IL114699A0 (en) |
| NO (1) | NO970081D0 (en) |
| WO (1) | WO1996003425A1 (en) |
| ZA (1) | ZA956137B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3734634B2 (en) * | 1999-03-03 | 2006-01-11 | ヒゲタ醤油株式会社 | Protein activation method and apparatus |
| US7521479B2 (en) | 2001-04-16 | 2009-04-21 | Panacea Pharmaceuticals, Inc. | Methods of treating prion disease in mammals |
| AU2003223936A1 (en) * | 2002-05-17 | 2003-12-02 | Kobenhavns Universitet | Method for purifying denatured proteins having a desired disulfide bond configuration |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR79124B (en) * | 1982-12-22 | 1984-10-02 | Genentech Inc | |
| ES8800957A1 (en) * | 1985-02-22 | 1987-12-01 | Monsanto Co | Method of somatotropin solubilization and naturation. |
| GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
| WO1992014832A1 (en) * | 1991-02-26 | 1992-09-03 | Ajinomoto Co., Inc. | Processes for purifying human bcdf |
| US5290920A (en) * | 1992-04-16 | 1994-03-01 | Allelix Biopharmaceuticals Inc. | Method of purifying human epidermal growth factor |
-
1995
- 1995-07-12 FI FI970230A patent/FI970230A0/en not_active Application Discontinuation
- 1995-07-12 JP JP8505402A patent/JPH11505507A/en active Pending
- 1995-07-12 AU AU31097/95A patent/AU3109795A/en not_active Abandoned
- 1995-07-12 EP EP95926859A patent/EP0804461A1/en not_active Withdrawn
- 1995-07-12 WO PCT/EP1995/002720 patent/WO1996003425A1/en not_active Ceased
- 1995-07-12 CA CA002194177A patent/CA2194177A1/en not_active Abandoned
- 1995-07-24 IL IL11469995A patent/IL114699A0/en unknown
- 1995-07-24 ZA ZA956137A patent/ZA956137B/en unknown
-
1997
- 1997-01-09 NO NO970081A patent/NO970081D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI970230A7 (en) | 1997-01-20 |
| JPH11505507A (en) | 1999-05-21 |
| AU3109795A (en) | 1996-02-22 |
| FI970230L (en) | 1997-01-20 |
| EP0804461A1 (en) | 1997-11-05 |
| WO1996003425A1 (en) | 1996-02-08 |
| FI970230A0 (en) | 1997-01-20 |
| NO970081D0 (en) | 1997-01-09 |
| CA2194177A1 (en) | 1996-02-08 |
| ZA956137B (en) | 1996-03-07 |
| IL114699A0 (en) | 1995-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI960309L (en) | High-level expression, purification and refolding of Neisseria meningitidis group B outer membrane porin proteins | |
| EE9700137A (en) | Aerosol forms of peptides and proteins | |
| DE3686654D1 (en) | METHOD FOR ISOLATING RECOMBINANT POLYPEPTIDES IN BIOLOGICALLY ACTIVE FORM. | |
| NO950461L (en) | Enteric composition including natural micellar casein | |
| DE69007975D1 (en) | FUSION PROTEIN CONSISTING OF GM-CSF AND IL-3. | |
| DK515989D0 (en) | PROCEDURE FOR ACTIVATING GENETICALLY MANUFACTURED AND PROCARYOTE EXPRESSED ANTIBODIES | |
| ATE339878T1 (en) | MYC-BINDING ZINC FINGER PROTEINS, THEIR PRODUCTION AND THEIR USE | |
| EP0540645A4 (en) | Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells | |
| AU583723B2 (en) | Process for renaturing of proteins | |
| NO970081L (en) | Method of folding proteins such as recombinant hirudin or epidermal growth factor | |
| ATE380873T1 (en) | PRENYLCYSTONE CARBOXYL METHYL TRANSFERASE, DNA CODING FOR THE SAME, AND A METHOD FOR SEARCHING FOR INHIBITORS | |
| DE68919848D1 (en) | AMPHIPHILE PEPTIDES AND THEIR USE. | |
| DE69836626D1 (en) | PROTEINS WITH LECITHIN CHOLESTEROL ACETYLTRANSFERASE-SIMILAR ACTIVITY, THEIR PREPARATION AND USE | |
| ES2168282T3 (en) | RECOMBINANT D-HYDANTOINASE, PROCEDURE FOR PREPARATION AND USE. | |
| ATE261985T1 (en) | METHOD FOR PRODUCING PROPERLY FOLDED, BIOLOGICALLY ACTIVE, RECOMBINANT PROTEIN | |
| DE59109261D1 (en) | POLYPEPTIDES DERIVED FROM HEPATITIS C-VIRUS PROTEINS AND THEIR USE | |
| ATE216706T1 (en) | PEPTIDES OF THE HIV GAG PROTEIN, THEIR PRODUCTION AND USE | |
| DK0467839T3 (en) | In vitro treatment of fusion proteins | |
| ATE495191T1 (en) | METHOD FOR RENATURING RECOMBINANT, DISULFIDE-CONTAINING PROTEINS AT HIGH PROTEIN CONCENTRATIONS IN THE PRESENCE OF AMINES | |
| ATE171711T1 (en) | CYCLOHEXAPEPTIDES AND MIXTURES THEREOF, METHOD FOR THE PRODUCTION AND THEIR USE | |
| FI905985L (en) | Method for solubilizing and denaturing somatotropins using low urea concentration | |
| WO1997041207A3 (en) | Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector | |
| DE59006998D1 (en) | METHOD FOR PRODUCING HIRUDINE. |